PRESS RELEASE published on 11/14/2024 at 15:31, 6 days 19 hours ago Further expansion of cost reduction programme Novacyt announces further expansion of cost reduction programme with proposed site consolidations expected to deliver c. £2.0m EBITDA improvement, including closure of Eastleigh site and transfer of Canada manufacturing operations to Manchester Cost Reduction EBITDA Improvement Manufacturing Operations Novacyt Site Consolidations
BRIEF published on 11/14/2024 at 15:31, 6 days 19 hours ago Novacyt launches new veterinary tests Gastrointestinal Diseases Novacyt Molecular Diagnosis Veterinary Tests Pathogens
BRIEF published on 11/01/2024 at 14:00, 19 days 20 hours ago Novacyt: Update on liquidity contract and voting rights Common Shares Voting Rights Liquidity Contract INVEST SECURITIES Novacyt
BRIEF published on 11/01/2024 at 13:57, 19 days 20 hours ago Novacyt Updates on Liquidity Agreement and Voting Rights Liquidity Agreement INVEST SECURITIES Total Voting Rights French Law Novacyt Shares
PRESS RELEASE published on 11/01/2024 at 13:52, 19 days 20 hours ago Liquidity Agreement and Total Voting Rights Novacyt provides liquidity agreement update and total voting rights information, with Invest Securities purchasing and selling ordinary shares. Company divided into clinical, instrumentation, and research use segments Ordinary Shares Liquidity Agreement Total Voting Rights Novacyt Clinical Diagnostics
BRIEF published on 10/31/2024 at 10:28, 21 days ago Dr. Ian Gilham Joins Novacyt as Non-Executive Director Life Sciences Board Appointment Non-Executive Director Novacyt Dr. Ian Gilham
BRIEF published on 10/31/2024 at 10:25, 21 days ago Appointment of Dr Ian Gilham to the Board of Directors of Novacyt Board Of Directors Life Sciences Appointment Novacyt Ian Gilham
PRESS RELEASE published on 10/31/2024 at 10:23, 21 days ago Directorate Change Novacyt appoints Dr Ian Gilham as Non-Executive Director, bringing expertise in life sciences companies to strengthen the Board Life Sciences Non-Executive Director Novacyt Dr Ian Gilham AIM-listed
BRIEF published on 10/17/2024 at 11:47, 1 month 3 days ago IVDR Certification for Yourgene® Cystic Fibrosis Test by Novacyt Screening Novacyt IVDR Cystic Fibrosis Yourgene
BRIEF published on 10/10/2024 at 12:28, 1 month 10 days ago Novacyt closes its IT-IS International subsidiary EBITDA Closing Novacyt IT-IS International PCR Market
Published on 11/21/2024 at 10:03, 39 minutes ago Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 42 minutes ago BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 42 minutes ago ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 7 minutes ago Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 17 minutes ago Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Published on 11/21/2024 at 10:30, 11 minutes ago MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 37 minutes ago Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 39 minutes ago Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 41 minutes ago Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 41 minutes ago Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV
Published on 11/21/2024 at 06:58, 3 hours 44 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 22 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 16 hours 57 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 16 hours 57 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 2 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
